Solstice Advanced Materials, Inc. (SOLS) Guidance & Earnings Results

On 2026-07-30 Solstice Advanced Materials, Inc. raised guidance: "FY26 net sales raised to $4,125-$4,185M from $3,900-$4,100M; FY26 adjusted EBITDA raised to $1,035-$1,055M from $975-$1,025M; FY26 adjusted diluted EPS raised to $2.75-$2.95 from $2.45-$2.75; FY26 capex raised to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SOLSSolstice Advanced Materials, Inc.Follow SOLS — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 9.4B
P/E TTM: 45.4
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
30 Jul 26	Raised	FY26 net sales raised to $4,125-$4,185M from $3,900-$4,100M; FY26 adjusted EBITDA raised to $1,035-$1,055M from $975-$1,025M; FY26 adjusted diluted EPS raised to $2.75-$2.95 from $2.45-$2.75; FY26 capex raised to $420-$440M from $400-$425M; Q3 2026 net sales guidance $990-$1,030M · full year
6 May 26	Reaffirmed	Full-year 2026 guidance reaffirmed · full year
11 Feb 26	Raised	FY2026 Net Sales $3.9-$4.1B, Adjusted EBITDA $975-$1,025M, Adjusted Diluted EPS $2.45-$2.75 · full year
6 Nov 25	Reaffirmed	Full-year 2025 Net Sales $3.75-$3.85B, ~25% Adjusted Standalone EBITDA Margin · full year

Solstice Advanced Materials, Inc. — questions

What guidance did Solstice Advanced Materials, Inc. give?: On 2026-07-30: "FY26 net sales raised to $4,125-$4,185M from $3,900-$4,100M; FY26 adjusted EBITDA raised to $1,035-$1,055M from $975-$1,025M; FY26 adjusted diluted EPS raised to $2.75-$2.95 from $2.45-$2.75; FY26 capex raised to $420-$440M from $400-$425M; Q3 2026 net sales guidance $990-$1,030M"
When does Solstice Advanced Materials, Inc. report earnings?: Solstice Advanced Materials, Inc.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from Solstice Advanced Materials, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.